Diferencias clave: Mecanismo de Accin: Tirzepatida: Agonista dual GIP y GLP-1 (dos hormonas) Semaglutida: Agonista nico GLP-1 (una hormona) Resultados de Prdida de Peso: Tirzepatida: Promedio de 16-23% de prdida de peso (ensayo SURMOUNT-1) Semaglutida: Promedio de 14.9% de prdida de peso Efectos Secundarios: Tirzepatida: Algunos pacientes reportan menos efectos secundarios gastrointestinales Semaglutida: Reportes ms comunes de nuseas y vmitos Sensibilidad a Insulina: Tirzepatida: Puede mejorar sensibilidad a insulina ms eficientemente Semaglutida: Buena regulacin de insulina Grasa Abdominal: Tirzepatida: Particularmente efectiva dirigindose a rea abdominal Semaglutida: Reduccin general de grasa Ambos medicamentos funcionan mejor cuando se combinan con dieta balanceada, actividad fsica regular y chequeos mdicos consistentes
Diarrhea and other GI symptoms affect roughly 2025% of patients starting tirzepatide therapy, but the duration and severity vary significantly between individuals
Quality Assurance: Moisture-proof, light-proof, and shock-resistant bundling keeps up item stability
Thats likely why more employers (an estimated 45% of them) cover bariatric surgery for employees, and some insurers are even finding ways to expand access to these procedures
At week 36, the eating behavior data showed even stronger results than at week 24 for higher doses
Yet, the evidence base is very limited, especially in humans
